Background: The prevalence of type 2 diabetes mellitus is rapidly increasing. Myocardial dysfunction may be a consequence of diabetic cardiomyopathy and it contributes to the poor prognosis of diabetic patients.
Introduction
TYPE 2 diabetes mellitus is a major risk factor for ischemic heart disease and may cause cardiomyopathy. Heart failure has a worse prognosis in diabetic than in non-diabetic patients. Evidence of Correspondence to: Dr. Shaimaa A. Mostafa, E-mail: shaimaa.desouky@fmes.bu.edu.eg diastolic dysfunction appears early inthe natural history of type 2 diabetes mellitus and evidenceof impaired systolic function may subsequently become apparent [1] .
Early detection of diabetic heart disease is of paramount importance, because life-style modifications and medical interventions could prevent or delay the subsequent development of heart failure [2] .
Early manifestation of diabetic LV systolic dysfunction appeared longitudinally, because subendocardialfibers, which are prone vulnerable to myocardial ischemia, have a longitudinal trajectory. The presence of impaired longitudinal function in diabetic patients has been reported when using tissue Doppler imaging [3] .
Even a mild degree of diastolic dysfunction has prognostic impact. Accordingly, there is a need for a sensitive and easily applied technique for the detection and follow-up of myocardial dysfunction in the diabetic patient before clinical evidence of compromised cardiac function is apparent. This has not been achieved by traditional two dimensional echocardiography or Doppler-based studies mitral inflow pattern [4] .
Aim of the study:
Early detection and quantification of myocardial dysfunction indiabetic patients.
Patients and Methods
The study included 60 cases (30 patients with type 2 DM and 30 control cases); who were referred to Benha University Hospital, Cardiology Department Echocargiography Unit from Nov. 2012 -Feb. 2013. All patients had normal LVEF with no regional wall motion abnormalities on 2D echocardiography.
164 Tissue Doppler Image During Dobuatmine Stress
Diabetes mellitus (DM) was diagnosed according to World Health Organization (WHO) and the American Diabetes Association (ADA) as fasting blood glucose ≥ 126mg/dL (≥7.0mmol/L) or 2 hour post-load plasma glucose ≥200mg/dL ( ≥ 11.1 mmol/L) or random plasma glucose ≥200mg/dL [5] or when patients on regular hypoglycemic drugs or insulin.
Exclusion criteria included a history of coronary artery disease or evidence of ischemia in surface ECG, the presence of moderate-to-severe valvular heart disease, and/or significant rhythm disturbances.
Echocardiography:
Patients were imaged in the left lateral decubitus position using a commercially available system (Vivid 7, General Electric-Vingmed). Images were obtained, with a simultaneous ECG signal.
Conventional echo study:
2D images were acquired during breath hold and saved in cine-loop format from three consecutive beats. The biplane Simpson's technique was used to calculate LV end-systolic volume (ESV), LV end-diastolic volume (EDV) and LVEF. 
Tissue doppler study:
By activating tissue Doppler image function in the echocardiography machine, the mitral annular velocities were recorded using the pulsed-wave DTI. From the apical 4-and 2-chamber views, the longitudinal mitral annular velocities were recorded from septal, lateral, inferior and anterior LV sites. A mean value for the above four sites were used. Three major velocities were taken into account: The positive peak systolic velocity when the mitral ring move toward the cardiac apex due to longitudinal contraction of the LV, and two negative diastolic velocities when the mitral annulus move toward the base away from the apex, one during the early phase of diastole and the second wave in the late phase of diastole. A mean of three consecutive cycles was used to calculate all echo-Doppler parameters twice (at rest and during the peak stress test).
Stress echo:
The patients abstain from all oral intakes for at least 3 hours before the procedure. ß-blockers were withheld 48 hours before testing.Dobutamine was administrated intravenously by an infusion pump at a starting dosage of 10 µ g/kg/min. At 3minute intervals, the dosage is increased to 20, 30, and 40µ g/kg/min until a pre-determined endpoint was reached. If neither target heart rate (85% of age-predicted maximal heart rate) nor any of the other endpoints was reached, the infusion rate was increased up to 50 µ g/kg/min for 3min., or atropine was administrated intravenously. A dose of 0.25 to 0.5mg of atropine was repeated at 1 minute intervals to a maximal dose of 2mg or until an endpoint was reached and dobutamine infusion is continued during atropine administration. Throughout the dobutamine infusion the ECG was continuously monitored and recorded at 1min. intervals and BP is recorded every third minute. End-points for interruption of the test were: 1-Achievement of target heart rate; 2-Maximal dose of both dobutamine and atropine; 3-Extensive new wall motion abnormalities; 4-Severe angina; 5-Symptomatic reduction in systolic blood pressure >40mmHg from baseline; 6-Hypertension (blood pressure >240/120mmHg); 7-Significant arrhythmias or 8-Any serious side effect regarded as being due to dobutamine infusion [6] .
Statistical analysis:
Data are presented as mean ± standard deviation for normally distributed quantitative data, and as number and percentages for categorical data. Chi square test (X 2 ) "Z" test and student " t" tests were used for between groups comparison in qualitative and quantitative data respectively. Paired sample t-test was used for within group comparison.
Results
The study included 60 patients divided into two groups: Group (I) included 30 diabetic patient and group (II) included 30 control cases of comparable age and gender and insignificant difference diabetes, BMI, smoking and hypertension ( At rest all conventional echocardiography parameters were within normal in both groups (Table  2) but by activation of the tissue Doppler velocity diabetic group showed statistically significant lower Em (p<0.01), higher Am (p<0.02) and lower E/A (p<0.001) and insignificant lower Sm (Table 3) . At peak stress there were significant increase in all tissue Doppler parameters in both groups but the degree of increase was more pronounced in the control group and the difference in Em, Sm and Am were statistically significant ( p<0.001) ( Tables  3,4 ) and Figs. (1,2 Fig. (1) : Comparison between resting and peak TDI parameters between 2 groups. Fig. (2) : Comparison between the percent of increase in TDI parameters at peak stress between 2 groups 
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Discussion
Patients with diabetes are at a greater risk of cardiovascular disease than individuals who are not diabetic and they suffer significantly greater rates of cardiovascular mortality. Cardiovascular disease accounts for up to 80% of mortality in patients with type 2 diabetes and the age-adjusted relative risk of cardiovascular death is three times greater in these patients than in the general population [7] .
It has been demonstrated that cardiovascular risk increases before the onset of diabetes is associated, not just with increased cardiovascular disease, but also with a worse outcome. One reason for this appears to be enhanced myocardialdysfunction leading to diabetic cardiomyopathy whichpredisposes patients to congestive heart failure [8] .
Several factors probably underline this condition: Chronic hyperglicemia, severe coronary atherosclerosis, microvascular disease, prolonged hypertension, glycosylation of myocardial proteins and autonomic neuropathy. According to all, early detection of clinical and subclinical cardiovascular disease in diabetic patients has important therapeutic and prognostic implications. Stress echocardiography and DTI are one the most-effective imaging techniques for assessing myocardial function and ischemia in hyperglicaemic asymptomatic patients.
Our results confirm that PW-DTI is a useful method in the quantification of regional myocardial velocity and that measurement of regional myocardial function can identify the presence of myocardial dysfunction in basal condition as well as during DES. We showed significantly lower baseline values of Em and ratio E/A; higher Am and lower Sm in diabetic patients than in control subjects [8] .
Our results for baseline peak myocardial velocity at early diastole and atrial contraction as well as for ratio E/A in diabetic patients reproduced values of the same parameters found by Elnoamany et al., [9] .
The present study showed significantly lower basal Em and ratio E/A in diabetic patients indicating the presence of diastolic myocardial dysfunction. Galderisi hasshown that diastolic filling abnormalites are common in patients with type 2 diabetes, which may represent early subclinical alterations in cardiac function [10] .
Also increase in Em, Am, Sm and ratio E/A during DSE in both examined groups were found, but the rate of these changes was morefavorable in controls than in diabetic patients. Impaired response of myocardial function during DSE in diabetic patients resulted in more significant difference in Emand significant difference in Sm between the two examined groups, after DSE. Our results are similar to those reported by Bibra et al., [11] , who described the use of PW-DTI in diabetic patients during dobutamine/dipyridamole stress echocardiography. The results of this study emphasized the value of Doppler tissue velocity sampling for the assessment of myocardial function in patients with type 2 diabetes mellitus. Early detection of impaired myocardial function using PW-DTI, signals the need for institution of more aggressive preventive measures in diabetic patientswith subclinical cardiovascular disease.
Conclusion:
In the evaluation of myocardial function, PW-DTI is an important step in the effort to objectively assess early signs of myocardial dysfunction. Quantitative PW-DTI in type 2 diabetic patients identified early signs of predominant diastolic and also systolic myocardial dysfunction.
Application of stress echocardiography with PWDTI increases the diagnostic capacity of stress echo in detection of myocardial impairment in diabetic patients with subclinical cardiovascular disease.
